Meningococcal vaccine refers to any of the vaccines used to prevent infection by neisseria meningitidis. The introduction of the meningococcal b menb vaccine. They are written by uk doctors and based on research evidence, uk and european guidelines. Since protection wanes, cdc recommends a booster dose at age 16. Meningococcal disease the australian immunisation handbook. The menb vaccine is recommended for babies aged 8 weeks, 16 weeks and 1 year as part of the nhs routine childhood vaccination programme. Outstanding doses should be administered where the routine childhood immunisation schedule has not been completed. Child must be 2 years old by 31 august to receive influenza vaccine in routine programme in autumnwinter. Jun 11, 2019 common side effects of bexsero include pain at the injection site, muscle pain, skin redness, fatigue, headache, a hard lump where the vaccine was injected, nausea, and joint pain.
A vaccine to protect against meningococcal subtype b bexsero was approved for use in australia in march of this year. Influenza vaccine effectiveness in preventing influenzaassociated hospitalisations during. Adverse eventsresponses following immunisation can range from mild to severe and from common to very rare. Bexsero meningococcal group b vaccine is a vaccine indicated for active immunization to prevent invasive disease caused by neisseria meningitides serogroup b. Meningococcal immunisation information for public health professionals. If you have any concerns about how this vaccine is to be given, talk. Vaccines indicated for adults based on medical indications.
Getting vaccinated helps protect you and those around you by increasing the level of immunity in the population. Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020. Fever is a potential risk factor for the development of a seizure. Active immunisation against invasive disease caused by neisseria meningitidis serogroupb strains. For example, in the uk, the jcvi advised that a carriage study in adolescents be carried out to determine the impact of bexsero on meningococcal carriage acquisition, as this would provide additional information on the costeffectiveness of the vaccine. The australian technical advisory group on immunisation consults with stakeholders on proposed changes to vaccination recommendations for inclusion in the australian immunisation handbook. For more details see chapters 4 and 11 in the green book. Immunisation with bexsero is intended to stimulate the production of bactericidal antibodies that recognize the vaccine antigens nhba, nada, fhbp, and pora p1. For advice on dosing schedules for missed vaccinations, and the immunisation of individuals coming to the uk, consult chapter 11, the uk immunisation schedule, in immunisation against infectious disease the green book. Bexsero is approved for use in individuals 10 through 25 years of age. Any medical event occurring after immunisation can be classified as an adverse event following immunisation aefi whether the event has any causal relationship to getting the immunisation or not. Immunisation is one of the most effective healthcare interventions. Immunisation patient group direction pgd templates gov.
Routine immunisation schedule wales from october 2017. Bexsero is a vaccine indicated for active immunization to prevent invasive disease caused by. Different versions are effective against some or all of the following types of meningococcus. Bexsero is a vaccine which is available as a suspension for injection in a prefilled syringe. Updated guidance for yellow fever green book chapter 35. They may occur as a result of the immunisation, a causal relationship between the event and. Hard copies of the schedules are available for ordering using the cdcinfo on demand. Vaccines indicated for adults based on medical indications cdc. The complete routine immunisation schedule isle of man government. The chapter has been updated to provide clarification on the use of prophylactic paracetamol when bexsero is administered concomitantly with other vaccines in infants. All vaccines are given intramuscularly unless otherwise stated. It is important to follow the instructions from your doctor or nurse so that you or your child completes the course of injections. These monitoring activities have found no new or unexpected safety issues. Immunisation against infectious disease the green book latest edition.
Bexsero meningococcal group b vaccine for injection in pre. Our open innovation strategy is designed to promote change beyond gsk by sharing expertise, resources intellectual property and knowhow with external researchers and the scientific community in australia and across the globe. Antibody levels correlate with protection against clinical disease. Adverse events following immunisation immunisation advisory. The second dose should be given at least one month after the first dose. The immunisations range from birth through to adulthood. Mar 20, 20 meningococcal immunisation information for public health professionals. Get information on ordering vaccines and access resources for promoting immunisation in the community. Contraindications and special considerations immunisation against. Information for public health professionals on immunisation. If you use assistive technology such as a screen reader and need a version of this document in a more accessible format. Proposed changes to the recommended use of the pneumococcal vaccine. Bexsero is now licensed in more than 35 countries worldwide for varying age groups, including the eu, australia, brazil, canada, chile, uruguay and the usa. Sep 07, 2016 bexsero, included in the uk infant immunisation schedule in september 2015, combines the protein antigens factorh binding protein fhbp, neisserial adhesion a nada, neisserial heparinbinding antigen nhba and pora with an outer membrane vesicle from the menzb vaccine.
This vaccine is like no other licensed vaccine and poses a number of implementation and surveillance challenges in england. The impact of invasive disease in different age groups as well as the variability of antigen. Vaccine safety and adverse effects following immunisation. The department provides guidelines and advice to health professionals about immunisation.
It includes vaccines provided for children, adolescents and adults at increased risk of vaccine preventable disease. Meningitis b vaccine rejected by uk society the guardian. Haemophilus influenzae type b hib influenza menacwy menb pcv toany age v fromtw oyears f age annual flu vaccine4 1. Menb vaccine in to the infant programme may provide a degree of. The green book immunisation against infectious disease. The recommendations for scheduled immunizations have been updated in line with the nhs england letter the national flu immunisation programme 201920 nhs england, 2019, and the chapter the uk immunisation schedule in the public health england phe document immunisation against infectious disease green book to include hpv vaccination in. Common side effects of bexsero include pain at the injection site, muscle pain, skin redness, fatigue, headache, a hard lump where the vaccine was injected, nausea. Dtapipvpoliohibhepb 6inone injection, 3rd dose infanrix hexa. If you use assistive technology such as a screen reader and need a version of this document in a more accessible format, please email. The following recommendations reflect advice produced by public health england. These guidelines are based on the best scientific evidence available at the time of publication, from published and unpublished literature. This questions and answers sheet for health care professionals provides basic information only. Clinical experience with the meningococcal b vaccine.
The complete routine immunisation schedule nhs england. Influenza is recommended for all children over 6 months. Learn how to display current schedules from your website. It is free for those with chronic medical conditions such as severe asthma. It contains parts of the bacteria neisseria meningitidis n. Adolescent meningococcal vaccination for providers cdc.
The flu chapter of the green book has been updated to reflect the latest guidance from the joint committee on vaccination and immunisation in readiness for the 2015 to 2016 influenza season. Latex in vaccine packaging immediatetype allergic reactions due to latex allergy have been described after vaccination, but such reactions are rare. Latex in vaccine packaging centers for disease control. Meningococcal group b vaccine meningitis research foundation. Immunisation schedule victoria november 2019 pdf, 74 kb.
It is unknown if bexsero can be interchanged with other meningococcal group b vaccines to complete the series. Bexsero is approved for use in individuals aged 10 through 25 years. The immunisation guidelines for ireland are only available online. Influenza immunisation information including updates for public health professionals. There is a marked seasonal variation in meningococcal disease, with peak levels in the winter months declining to low levels by late summer. Recommendations specific to each vaccine can be found in immunisation against infectious disease the green book. Bexsero is expected to protect against most circulating meningococcal b strains. Although meningitis b is uncommon, its not a chance you want to take. The vaccines are between 85 and 100% effective for at least two years. For advice on dosing schedules for missed vaccinations, and the immunisation of individuals coming to the uk, consult chapter 11, the uk immunisation schedule, in immunisation against infectious disease the green.
The impact of invasive disease in different age groups as well as the variability of antigen epidemiology for group b strains in different geographical areas should be considered when vaccinating. The menb vaccine will protect your baby against infection by meningococcal group b bacteria, which are responsible for more than 90% of meningococcal infections in young children. To any ag ein seve rimmunosupp ession medical condition diseases protected against vaccines required 2 asplenia or splenic dysfunction including sickl ecell andcoeliac disease meningococcal groups a, b, c, w and y pneumococcal haemophilu sinfluenza typ b hib influenza hibmenc. Bexsero is given as an injection, usually into your or your childs arm or leg muscle. Find out more about vaccination for children, adolescents and adults, including schedule, eligibility and reporting adverse events. This fact sheet provides basic information for the public.
Bexsero is given to individuals from 2 months of age and older to. Meningococcal b menb vaccine is routinely given to babies in the uk and ireland at 2, 4 and 12 months. If you use assistive technology such as a screen reader and need a. The immunisation unit at act health manages the act immunisation program, providing government funded vaccines to all immunisation providers in the act. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. It is theoretically possible that latex protein from these tip caps, plungers or vial stoppers may. The green book has the latest information on vaccines and vaccination procedures, for vaccine preventable infectious diseases in the uk. National immunisation office we provide trusted, uptodate information about hse immunisation programmes for children, adults and healthcare professionals in ireland. In 20, bexsero became the first broadcoverage vaccine to be licensed for active immunisation against menb disease. This year there is a new quadrivalent vaccine which covers an extra b strain.
Bexsero is a 2dose vaccine series given in the muscle of the upper arm. Follow the recommended immunization schedule to ensure that your patients get the meningococcal vaccines that they need. Other vaccines may be recommended for certain individuals. Where there is a discrepancy in the recommendations in different chapters, the recommendation in the most recent chapter should be followed. Effective december 2014, ontario has introduced the multicomponent meningococcal b vaccine. Meningococci are gramnegative diplococci, divided into antigenically distinct capsular groups.
If a person reports a severe anaphylactic allergy to latex, vaccines supplied in vials or syringes that contain natural rubber latex should be avoided if possible. The national immunisation program nip schedule is a series of immunisations given at specific times throughout your life. In september 2015, the united kingdom was the first country to introduce bexsero gsk biologicals, a novel, multicomponent vaccine against meningococcal group b menb disease, into the national infant immunisation programme. All injected vaccines are given intramuscularly unless otherwise stated.
All 11 to 12 year olds should receive a single dose of meningococcal conjugate menacwy vaccine. Since september 2015 uk babies born on or after 1 july 2015 have been offered the menb meningococcal group b vaccine as part of the routine immunisation schedule and babies born on or after 1 may were offered the vaccine as part of a one off catchup campaign. The immunisation handbook 2017 the handbook provides clinical guidelines for health professionals on the safest and most effective use of vaccines in their practice. We provide trusted, uptodate information about hse immunisation programmes for children, adults and healthcare professionals in ireland. Contraindications and special considerations in addition, immunisation with live vaccines should be delayed until 6 months of age in children born to mothers who received immunosuppressive biological therapy during pregnancy. In victoria the routine schedule of vaccines is provided free under the national immunisation program and the victorian funded immunisation program. The tga has been closely monitoring reports of adverse events following immunisation with bexsero meningococcal b vaccine, specifically those relating to fever in infants and children. Dec 07, 2019 provides accurate and independent information on more than 24,000 prescription drugs, overthecounter medicines and natural products. Clinical experience with the meningococcal b vaccine, bexsero.
Influenza each year from september live influenza vaccine fluenz tetra 2,3 both nostrils 3 years 4. Summary of recent issues considered by four national immunisation. Cdc recommends meningococcal vaccination for all adolescents. The influenza immunisation recommendations reflect advice from the national flu. All parties are welcome to make a submission on draft recommendations. Feb, 2020 professional reference articles are designed for health professionals to use. Bexsero is used to protect individuals from the age of two months. The united kingdom is the first country to introduce bexsero gsk biologicals, a multicomponent, proteinbased vaccine against meningococcal group b menb, into the national infant immunisation programme. Check relevant chapter of green book for specific schedule 3. It is not intended to provide or take the place of medical advice, diagnosis or treatment. You may find the immunisation article more useful, or one of our other health articles.
All injected vaccines are given intramuscularly unless stated otherwise. Some adults may need another type of meningitis vaccine, the serogroup b meningococcal vaccine, if they. Mar 20, 20 the flu chapter of the green book has been updated to reflect the latest guidance from the joint committee on vaccination and immunisation in readiness for the 2015 to 2016 influenza season. Immunisation schedule treatment summary bnf content. Bexsero induces bactericidal antibodies specific to the 4 vaccine antigens in infants, children, adolescents and younger adults. Bexsero is a vaccine approved to help prevent meningitis b. Influenza annual and ppv pneumococcal polysaccharide. Distribution of bexsero antigen sequence types basts in. Anaphylaxis updated february 2019 changes to online chapters of 20 immunisation guidelines 10 january 2014.
1584 619 583 1067 88 86 9 489 297 1014 700 1006 1372 1394 511 848 1424 1587 822 302 606 1280 209 878 51 598 182 53 1576 1193 49 24 494 989 1477 908 39 536 801 1429 763 1049 190 589 974 1254 701 677